hemotune raises CHF 14 million Series B2 funding for clinical trials with the HemoSystem

Dual Award Winning

Recognition as one of the Top Innovative Companies 2024

Revolutionizing Blood Purification: hemotune Attains ISO 13485 Certification

hemotune’s Founder and CEO Lukas Langenegger Named Digital Shaper 2023!

Hemotune receives grant from Innosuisse

Lukas Langenegger selected as a UBS Global Visionary: A magnetic force for healthcare

hemotune AG initiates joint feasibility project on the HemoSystem with AstraZeneca

Welcome to the team of hemotune

Successful completion of Wyss Zurich project hemotune